Search Results 1041-1050 of 17733 for corticosteroid

1. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   corticosteroids (non-US sites only). Neurological exam free of clinically significant, unexplained signs or symptoms during screening and no clinically ...

2. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   NOTE: Prior treatment with corticosteroids (maximum dose of corticosteroids should not exceed the equivalent of 160 mg of dexamethasone over 14 days.

3. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Concurrent, recent (≤ 4 weeks ago) or anticipated treatment with systemic corticosteroids at any dose, or; Other immunosuppressive medications such as ...

4. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

   The purpose of this study is to confirm that adding custirsen to standard first-line docetaxel and prednisone treatment can slow tumor progression in men who ...

5. Neoadjuvant Pembrolizumab - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs). Replacement therapy (e.g. thyroxine, insulin or physiologic corticosteroid replacement therapy for adrenal ...

6. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs). Note: Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid replacement therapy for ...

7. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

   Patients who are on replacement doses of corticosteroids when coming onto study may continue those steroids while on study. Patients who have partners of ...

8. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

   If currently not using corticosteroids, must not have received oral corticosteroids for at least 2 weeks prior to the first administration of study agent; If ...

9. A Study of Aplidin for Treating Patients with Primary Myelofibrosis, Post Polycythemia Vera or Essential Thrombocythemia Myelofibrosis - Mayo Clinic

   Corticosteroids >10 mg/day prednisone or equivalent; Erythropoietin. Incomplete recovery from major surgery within four weeks of study entry; Radiation therapy ...

10. Tendinitis - Symptoms and causes - Mayo Clinic

    Corticosteroids such as cortisone; Aromatase inhibitors, used to lower breast cancer risk. Complications. Without treatment, tendinitis can increase the risk ...